South Korea Protein Expression Market (2026-2031)
The South Korea Protein Expression Market was valued at $58.9 Million in 2026 and projected to reach to $86.7 Million by 2031, representing a compound annual growth rate of 8.1%. South Korea's protein expression market is positioned for sustained growth through 2031, driven by increasing R&D investments and the country's strategic focus on becoming a global biotechnology leader.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Protein Expression Market Trends and Insights
- This expansion reflects South Korea's strengthening position as a biotechnology hub in Asia Pacific, driven by increasing investments in research and development infrastructure.
- South Korea's advanced healthcare ecosystem and growing pharmaceutical sector are catalyzing demand for sophisticated protein expression technologies and services. The protein expression market in South Korea is benefiting from rising adoption of recombinant protein production across therapeutic development and diagnostics.
- South Korea's emphasis on precision medicine and biopharmaceutical innovation is accelerating market penetration of expression systems including mammalian, bacterial, and cell-free platforms.
- By 2031, South Korea is expected to consolidate its role as a key regional player, supported by government initiatives promoting biotechnology commercialization and academic-industry collaboration..
Key Market Statistics
- CAGR (2026-2031) 8.1% CAGR
- Market Size, 2026 ~USD 58.9 Million
- Forecast, 2031 ~USD 86.7 Million
- Country South Korea
South Korea Protein Expression Market Overview
Market Valuation Growth :
South Korea's protein expression market is valued at $58.9 million in 2026, with a projected CAGR of 8.1% through 2031, reaching $86.7 million by forecast end.
Biotech Hub Expansion :
South Korea is establishing itself as a leading biotechnology hub in Asia Pacific, with significant government and private sector investments in research and development infrastructure.
Healthcare Ecosystem Strength :
The country's advanced healthcare system and robust pharmaceutical industry provide a strong foundation for protein expression technology adoption and innovation.
Regional Competitive Position :
South Korea's protein expression market growth rate of 8.1% demonstrates competitive momentum within the Asia Pacific region's biotechnology landscape.
South Korea Protein Expression Market Dynamics
- The expanding pharmaceutical sector and government support for life sciences innovation are creating favorable conditions for market expansion.
- South Korea's skilled workforce, advanced research facilities, and strong intellectual property framework are attracting both domestic and international biotech companies to establish operations and invest in protein expression technologies.
- This momentum is expected to accelerate as the country continues to develop its biopharmaceutical manufacturing capabilities and strengthen its position in the competitive Asia Pacific market..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- South Korea's protein expression market will grow from $58.9M (2026) to $86.7M (2031), representing 47% absolute growth over the forecast period.
- South Korea maintains an 8.1% CAGR, slightly below the global average, reflecting mature market dynamics balanced with emerging opportunities.
- South Korea's biopharmaceutical sector expansion and government R&D incentives are primary drivers of protein expression technology adoption.
- South Korea is positioned as a regional innovation center, with increasing demand for advanced expression platforms supporting therapeutic development.
Protein Expression Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SOFTWARE (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 8.3% from 2026 to 2031 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 5.13 (2026) |
| Revenue Forecast (Billions) | ~USD 7.65 (2031) |
| Segments Covered | Offering, Type, End User, Workflow, Scale Of Operation, Protein Modality, Application |
South Korea Protein Expression Market Report Segmentation
7 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Algal & Plant-Based Expression Systems
- Algal-Based Expression Systems
- Analytical Instruments
- Bacillus Systems
- Baculovirus Systems
- Bioreactors & Fermenters
- Cell-Free Expression Systems
- Cho Cell Systems
- Chromatography & Purification Consumables
- Chromatography Systems
- Cld Services
- Cloning & Mutagenesis Kits
- Competent Cells
- Consumables
- Culture Media & Supplements
- Custom Protein Expression Services
- E. Coli Lysate-Based Systems
- E. Coli Systems
- Expression Kits
- Expression Vectors & Plasmids
- Filtration & Separation Consumables
- Filtration Systems
- Gene Synthesis & Cloning Services
- Hek 293 Cell Systems
- Insect Cell Expression Systems
- Instruments
- Kits
- Liquid Handling & Automation Systems
- Mammalian Cell Expression Systems
- Other Cell-Free Expression Systems
- Other Consumables
- Other Insect Cell Expression Systems
- Other Instruments
- Other Kits
- Other Mammalian Cell Expression Systems
- Other Prokaryotic Expression Systems
- Other Reagents
- Other Yeast Expression Systems
- Pichia Systems
- Process Development & Scale-Up Services
- Prokaryotic Expression Systems
- Reagents
- Saccharomyces Systems
- Software
- Transduction & Transfection Reagents
- Yeast Expression Systems
By End User
- Academic & Research Institutes
- Cros & Cdmos
- Other End Users
- Pharmaceutical & Biotechnology Companies
By Workflow
- Cloning & Transfection
- Extraction, Purification, And Characterization
- Transcription, Translation, And Post-Translational Modification (Ptm)
By Scale Of Operation
- Discovery & Research Scale
- Preclinical & Characterization Scale
- Process Development & Pilot Scale
By Protein Modality
- Enzymes & Catalytic Proteins
- Monoclonal Antibodies & Derivatives
- Other Proteins
- Recombinant Therapeutic Proteins
- Vaccines
By Application
- Diagnostic Applications
- Industrial Applications
- Research Applications
- Therapeutic Applications
Target Audience
- Biotech Companies & Startups : South Korea-based and international biotech firms need market sizing and growth projections to evaluate expansion opportunities, R&D investments, and commercialization timelines in the country.
- Pharmaceutical Manufacturers : Pharma companies require South Korea-specific market data to assess protein expression technology adoption rates, manufacturing capacity needs, and competitive positioning in this growing market.
- Investment & Venture Capital Firms : Investors targeting South Korea's biotech sector need validated market forecasts and growth metrics to identify promising companies, assess portfolio opportunities, and guide funding decisions.
- Research Institutions & Universities : Academic and research organizations in South Korea need market intelligence to align research initiatives with commercial opportunities and secure funding for protein expression technology development.
- Government & Policy Makers : South Korean government agencies and policy bodies require market data to inform biotech industry support programs, R&D incentives, and strategic initiatives to strengthen the country's biotech competitiveness.
Key Companies in the South Korea Protein Expression Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PATHEON INC | Netherlands | Private Company | Drug Product Services (finished dosage manufacturing & packaging),Pharmaceutical Development Services,Drug Substance Services (small- and large-molecule APIs), |
| NANOSTRING TECHNOLOGIES, INC | United States | Private Company | nCounter instruments and consumables (Pro, FLEX, SPRINT, CodeSets, panels, reagents),GeoMx DSP and spatial biology solutions,Prosigna and other in vitro diagnostic kits, |
| BIOGEN | United States | Public Company | Multiple Sclerosis therapies (TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, OCREVUS-related),SPINRAZA and rare neuromuscular (SPINRAZA, QALSODY, SKYCLARYS),Alzheimer’s and neuropsychiatry (LEQEMBI, ZURZUVAE), |
| SIGMA-ALDRICH CORPORATION | United States | Private Company | Pharma and biopharma manufacturing (media, filtration, critical raw materials, safety testing),Research reagents and molecular biology (chemicals, biochemicals, functional genomics, protein biology),Analytical chemistry, diagnostics, and industrial microbiology, |
| VIVA BIOTECH LTD | China | Public Company | Discovery biology & structural biology services,Medicinal and synthetic chemistry & CADD,CDMO & CMC/filing services, |
| CODEXIS, INC. | United States | Public Company | Biopharma process enzymes and custom engineering (CodeEvolver-based),ECO Synthesis and nucleic acid manufacturing solutions,Other life science and industrial enzyme applications, |
| MAXCYTE, INC | United States | Public Company | ExPERT ATx instruments and related consumables,ExPERT STx instruments and related consumables,ExPERT GTx instruments and related consumables, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| MERCK KGAA | Germany | Public Company | Life Science (reagents, consumables, bioprocessing, CDMO),Healthcare (oncology, neurology, fertility, rare diseases),Electronics (semiconductor and display materials, delivery equipment), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and bioproduction),Life Sciences (research and analytical instruments, genomics),Diagnostics (clinical instruments and consumables), |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| SARTORIUS AG | Germany | Public Company | Bioprocess solutions (bioreactors, cell culture, fluid management, process filtration),Analytical solutions (BLI, cytometry screening, PAT, live-cell imaging, SPR),Lab products and services (filtration, purification, lab water, weighing, pipettes, microbiological testing), |
| GENSCRIPT | Hong Kong | Public Company | Life Science Services and Products,Biologics Development Services,Industrial Synthetic Biology Products, |
| TAKARA BIO INC. | Japan | Private Company | Genetic and cellular research reagents,Instruments and cellular analysis devices,In vitro diagnostics (including COVID-19), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Research Instruments and Reagents,Other / Software and Services, |
| QIAGEN | Netherlands | Public Company | Sample technologies (extraction and purification consumables/instruments),PCR and enzymes (qPCR/dPCR instruments and reagents),Molecular diagnostic assays (TB, oncology, sexual and reproductive health, transplant/viral load), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Research Models and Services,Discovery and Safety Assessment,Manufacturing Solutions, |
| CORNING INCORPORATED | United States | Public Company | Optical communications (fiber, cable, hardware, equipment),Display glass substrates (LCD/OLED),Specialty materials and mobile consumer electronics glass, |
| LONZA | Switzerland | Public Company | Integrated Biologics (mammalian and drug product CDMO),Advanced Synthesis (small molecules, HPAPIs, ADCs, bioconjugates),Specialized Modalities (cell & gene, microbial, bioscience, mRNA), |
| FUJIFILM HOLDINGS CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, image sensors, functional films, storage),Business Innovation (office equipment, document services, graphic communications), |
| SYNGENE INTERNATIONAL LIMITED | India | Public Company | Discovery Services (chemistry, biology, computational),Development Services (preclinical, CMC, clinical development),Biologics and Specialty Modalities, |
| LGC LIMITED | South Korea | Public Company | Ethylene-based synthetic resins (PE, EVA, LLDPE, UNIQABLE),Styrene-based resins (ABS, ASA, PS, EPS, SAN),Polycarbonate and engineering plastics (LUMID/LUXY, LUMILOY, LUPOL, LUPOY, etc.), |
PATHEON INC
Patheon Inc is a Netherlands-based private company with 9,100 employees operating in the life sciences sector.
NANOSTRING TECHNOLOGIES, INC
NanoString Technologies, Inc is a United States-based private company founded in 2003 with 550 employees specializing in life sciences technology.
BIOGEN
Biogen is a United States-based public company founded in 1978 with 7,500 employees engaged in biotechnology and pharmaceutical development.
SIGMA-ALDRICH CORPORATION
Sigma-Aldrich Corporation is a United States-based private company founded in 1951 with 9,800 employees providing life sciences products and services.
VIVA BIOTECH LTD
Viva Biotech Ltd is a China-based public company founded in 2008 with 2,169 employees providing drug discovery and development services.
CODEXIS, INC.
Codexis, Inc is a United States-based public company founded in 2002 with 146 employees focused on enzyme engineering and biocatalysis.
MAXCYTE, INC
MaxCyte, Inc is a United States-based public company founded in 1998 with 91 employees specializing in cell engineering technology.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc is a United States-based public company founded in 1956 with 125,000 employees serving the life sciences and laboratory sectors globally.
MERCK KGAA
Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees operating as a diversified pharmaceutical and chemical company.
DANAHER CORPORATION
Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees engaged in life sciences, diagnostics, and environmental solutions.
AGILENT TECHNOLOGIES, INC.
Agilent Technologies, Inc is a United States-based public company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.
SARTORIUS AG
Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees specializing in laboratory and bioprocess equipment.
GENSCRIPT
GenScript is a Hong Kong-based public company founded in 2002 with 6,165 employees providing biotechnology research services and products.
TAKARA BIO INC.
Takara Bio Inc is a Japan-based private company founded in 2002 with 1,779 employees specializing in biotechnology research tools and services.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc is a United States-based public company founded in 1952 with 7,450 employees manufacturing life sciences research and clinical diagnostics products.
QIAGEN
Qiagen is a Netherlands-based public company founded in 1984 with 5,500 employees providing molecular diagnostics and life sciences research solutions.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees providing preclinical and clinical laboratory services.
CORNING INCORPORATED
Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees manufacturing specialty glass and materials for life sciences applications.
LONZA
Lonza is a Switzerland-based public company founded in 1897 with 20,000 employees providing pharmaceutical and biotechnology manufacturing services.
FUJIFILM HOLDINGS CORPORATION
Fujifilm Holdings Corporation is a Japan-based public company founded in 1934 with 73,526 employees operating across imaging, pharmaceuticals, and life sciences sectors.
SYNGENE INTERNATIONAL LIMITED
Syngene International Limited is an India-based public company founded in 1993 with 6,692 employees providing drug discovery and development services.
LGC LIMITED
LGC Limited is a South Korea-based public company founded in 1947 with 14,019 employees operating in life sciences and analytical testing services.
Reasons to Buy this Report
- Market-Specific Sizing Data : Access precise valuation figures for South Korea's protein expression market with verified 2026 baseline ($58.9M) and 2031 forecast ($86.7M) to inform investment and expansion decisions.
- Regional Growth Intelligence : Understand South Korea's 8.1% CAGR trajectory compared to global 8.3% performance, identifying localized growth drivers and competitive positioning within Asia Pacific.
- Biotech Ecosystem Insights : Gain detailed analysis of South Korea's strengthening position as a biotechnology hub, including R&D infrastructure investments and pharmaceutical industry dynamics affecting market growth.
- Strategic Market Entry Planning : Leverage South Korea-specific market intelligence to develop targeted go-to-market strategies, partnership opportunities, and investment priorities in the country's growing protein expression sector.
- Competitive Landscape Assessment : Evaluate South Korea's advanced healthcare ecosystem and regulatory environment to benchmark competitive advantages and identify market gaps for product development and commercialization.
Frequently asked questions
What is the current size of South Korea's protein expression market?
South Korea's protein expression market is valued at $58.9 million in 2026 and is expected to reach $86.7 million by 2031.
What is the projected growth rate for South Korea's protein expression market?
South Korea's protein expression market is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2031.
What factors are driving growth in South Korea's protein expression market?
Key drivers include South Korea's expanding biopharmaceutical sector, government R&D investments, increasing adoption of recombinant protein production, and emphasis on precision medicine and therapeutic innovation.
Which protein expression systems are most prevalent in South Korea?
South Korea's market encompasses mammalian, bacterial, and cell-free protein expression systems, with adoption driven by therapeutic development and diagnostic applications.
How does South Korea's protein expression market compare to global trends?
South Korea's 8.1% CAGR is slightly below the global average of 8.3%, reflecting a mature but steadily growing market with strong regional positioning in Asia Pacific.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current size of the protein expression market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. The secondary sources referred for this research study include publications from government sources, such as the National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Health Organization (WHO), Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceutical Research and Manufacturers of America (PhRMA), Global Cancer Observatory (GLOBOCAN), Centers for Disease Control and Prevention (CDC), and European Federation of Biotechnology,. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global protein expression market, and the findings were validated through primary research.
Primary Research
In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the protein expression market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Protein Expression Market : Top-Down and Bottom-Up Approach
Data Triangulation
After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.
Market Definition
The protein expression market encompasses the technologies, products, and services required for protein production and analysis. This market includes various expression systems (mammalian, bacterial, yeast, algal, insect, and cell-free), reagents and instruments for transfection and cloning, growth reagents for cell culture during translation, and reagents and kits for downstream processes such as purification and characterization. It serves industries such as pharmaceuticals, biotechnology, academic & research institutes, CROs & CDMOs, and other industrial users, supporting applications in drug discovery, therapeutic development, and biochemical research, as well as other industries such as food and beverages, cosmetics, and textiles, among others.
Key Stakeholders
- Protein Expression Instrument & Reagent Manufacturers
- Suppliers of Expression Systems
- National and regional research boards and organizations
- Research & development companies
- Clinical research organizations (CROs)
- Contract Manufacturing Organizations (CMOs)
- Biotechnology companies
- Research laboratories & academic institutes
- Market research & consulting firms
- Regulatory bodies
Report Objectives
- To define, describe, and forecast the protein expression market by offering, type, workflow, scale of operation, protein modality, application, product end user, service end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall protein expression market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC (Saudi Arabia, United Arab Emirates, and the Rest of GCC) and the Rest of Middle East], and Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy
Customization Options
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe protein expression market, by country
- Further breakdown of the Rest of Asia Pacific protein expression market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Cross-segment analysis
Get the Full Protein Expression Market Report
Full forecast, segment splits, and company analysis for all Protein Expression Market.
- Canada Protein Expression Market
- US Protein Expression Market
- Germany Protein Expression Market
- UK Protein Expression Market
- France Protein Expression Market
- Italy Protein Expression Market
- Spain Protein Expression Market
- Netherlands Protein Expression Market
- China Protein Expression Market
- Japan Protein Expression Market
- India Protein Expression Market
- Australia Protein Expression Market
- Brazil Protein Expression Market
- Mexico Protein Expression Market
- Argentina Protein Expression Market
- Saudi Arabia Protein Expression Market
- UAE Protein Expression Market
- Rest Of Europe Protein Expression Market
- Rest Of Asia Pacific Protein Expression Market
- Rest Of Latin America Protein Expression Market
- Rest Of GCC Countries Protein Expression Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report